Filar, I., M. Witkowski, W. Ryżewska, and T. Robak. “Recombinant ADAMT S-13 As a New Alternative for the Patients With Congenital Thrombocytopenic Purpura”. OncoReview, Vol. 14, no. 3(55), Dec. 2024, pp. 59-63, doi:10.24292/01.OR.143301224.